SCHEMBL21779385

SCHEMBL21779385

Cc1cc(-c2cnn(C)c2)cnc1N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.60
MAP4K4 O95819 2/20 0.50
IKBKE Q14164 1/20 0.49
TBK1 Q9UHD2 1/20 0.49
MET P08581 8/20 0.48
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
AURKA O14965 1/20 0.45
TTK P33981 1/20 0.45
AURKB Q96GD4 1/20 0.45
INCENP Q9NQS7 1/20 0.45
MAPK1 P28482 1/20 0.45
CSF1R P07333 1/20 0.45
FGFR1 P11362 1/20 0.44
FGFR2 P21802 1/20 0.44
FGFR3 P22607 1/20 0.44
PIK3R1 P27986 1/20 0.43
PIK3CA P42336 1/20 0.43
MTOR P42345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28764958 0.82 LRRK2 (0.48) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL21557014 0.81 LRRK2 (0.55) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL16679332 0.81 LRRK2 (0.55) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL21603501 0.80 ALDH1A1 (0.54) LRRK2METAURKATTKAURKB
SCHEMBL28516648 0.79 LRRK2 (0.52) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL29640807 0.79 LRRK2 (0.52) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL15358997 0.79 LRRK2 (0.89) LRRK2MAP4K4METMAPK1FGFR1
SCHEMBL15359091 0.78 LRRK2 (0.62) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL992070 0.78 ERN1 (0.55) LRRK2MAP4K4IKBKETBK1MET
SCHEMBL15333316 0.76 LRRK2 (0.72) LRRK2MAP4K4METMAPK1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3344613-B1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG A SOCIO HOLDINGS CO LTD (KR) 2020-03-04 EP disclosed